Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Leuprorelin acetate immediate-release vs depot in prostate cancer
CTR20132422Phase 2Suspended
- Sponsor
- Jilin Zixin Pharmaceutical
- Start
- Jan 2014
- Modality
- Small Molecules, Peptides
- Countries
- 1
01
Overview
A Phase 2 trial of leuprolide in prostate cancer (PCa), sponsored by Jilin Zixin Pharmaceutical. Started Jan 2014; status: suspended.
02
Drugs
leuprolide
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on CTR20132422.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20132422.